CLDX
Price
$18.30
Change
+$0.50 (+2.81%)
Updated
Apr 17 closing price
Capitalization
1.21B
12 days until earnings call
VIGL
Price
$1.71
Change
+$0.20 (+13.25%)
Updated
Apr 17 closing price
Capitalization
79.81M
18 days until earnings call
Ad is loading...

CLDX vs VIGL

Header iconCLDX vs VIGL Comparison
Open Charts CLDX vs VIGLBanner chart's image
Celldex Therapeutics
Price$18.30
Change+$0.50 (+2.81%)
Volume$457.87K
Capitalization1.21B
Vigil Neuroscience
Price$1.71
Change+$0.20 (+13.25%)
Volume$76.89K
Capitalization79.81M
CLDX vs VIGL Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. VIGL commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and VIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (CLDX: $18.30 vs. VIGL: $1.71)
Brand notoriety: CLDX and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 57% vs. VIGL: 36%
Market capitalization -- CLDX: $1.21B vs. VIGL: $79.81M
CLDX [@Biotechnology] is valued at $1.21B. VIGL’s [@Biotechnology] market capitalization is $79.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, VIGL is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while VIGL’s TA Score has 6 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 3 bearish.
  • VIGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CLDX and VIGL are a good buy in the short-term.

Price Growth

CLDX (@Biotechnology) experienced а +14.81% price change this week, while VIGL (@Biotechnology) price change was +11.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.22B) has a higher market cap than VIGL($79.8M). VIGL YTD gains are higher at: 0.588 vs. CLDX (-27.582). VIGL has higher annual earnings (EBITDA): -89.23M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. VIGL (97.8M). CLDX has less debt than VIGL: CLDX (3.81M) vs VIGL (12.9M). CLDX has higher revenues than VIGL: CLDX (7.02M) vs VIGL (0).
CLDXVIGLCLDX / VIGL
Capitalization1.22B79.8M1,523%
EBITDA-191.9M-89.23M215%
Gain YTD-27.5820.588-4,689%
P/E RatioN/AN/A-
Revenue7.02M0-
Total Cash725M97.8M741%
Total Debt3.81M12.9M30%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXVIGL
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 10 days ago
88%
Declines
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+2.81%
BEAM - CLDX
51%
Loosely correlated
+2.29%
DNLI - CLDX
50%
Loosely correlated
+1.51%
KYMR - CLDX
49%
Loosely correlated
+3.80%
NTLA - CLDX
47%
Loosely correlated
+5.39%
ATXS - CLDX
47%
Loosely correlated
+1.51%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with ALEC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
+13.25%
ALEC - VIGL
36%
Loosely correlated
-5.95%
CLDX - VIGL
36%
Loosely correlated
+2.81%
ELVN - VIGL
35%
Loosely correlated
+2.86%
FHTX - VIGL
35%
Loosely correlated
+9.51%
DNLI - VIGL
35%
Loosely correlated
+1.51%
More